DIIS: A BIOMEDICAL DATA ACCESS FRAMEWORK FOR AIDING DATA DRIVEN RESEARCH SUPPORTING FAIR PRINCIPLES



Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Modulation of the kallikrein-kinin system (KKS) has been shown to have beneficial effects on glucose homeostasis and several other physiological responses relevant to the progression of ORG PINEAPPLE CHUNKS type 2 diabetes mellitus (T2D).The importance of bradykinin and its receptors in mediating these responses is well documented, but the role of

read more